BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 19524096)

  • 1. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
    Honnorat J
    Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing paraneoplastic neurological disorders.
    de Beukelaar JW; Sillevis Smitt PA
    Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and management of paraneoplastic neurological syndromes].
    Saji E; Kawachi I; Nishizawa M
    Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic neurological syndrome and autoantibodies].
    Hayashi Y; Inuzuka T
    Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic neurological syndrome--definition and history].
    Inuzuka T
    Brain Nerve; 2010 Apr; 62(4):301-8. PubMed ID: 20420169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
    Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
    Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic neurological disorders.
    Blaes F; Tschernatsch M
    Expert Rev Neurother; 2010 Oct; 10(10):1559-68. PubMed ID: 20925471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against glial antigens in paraneoplastic neurological diseases.
    Tschernatsch M; Gross O; Kneifel N; Krasenbrink I; Gerriets T; Kaps M; Blaes F
    Ann N Y Acad Sci; 2007 Jun; 1107():104-10. PubMed ID: 17804537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic neurological syndromes: a review.
    Toothaker TB; Rubin M
    Neurologist; 2009 Jan; 15(1):21-33. PubMed ID: 19131854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic neurological syndromes: diagnosis and treatment.
    Graus F; Dalmau J
    Curr Opin Neurol; 2007 Dec; 20(6):732-7. PubMed ID: 17992098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on paraneoplastic neurological syndromes.
    Didelot A; Honnorat J
    Curr Opin Oncol; 2009 Nov; 21(6):566-72. PubMed ID: 19620862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
    Yamamoto T; Tsuji S
    Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].
    Ovadia H; Karussis D; Abramsky O
    Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis.
    Sabater L; Gómez-Choco M; Saiz A; Graus F
    J Neuroimmunol; 2005 Dec; 170(1-2):186-90. PubMed ID: 16165222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.